Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)

China · Delayed Price · Currency is CNY

3.820

-0.060 (-1.55%)

Sep 8, 2026, 3:04 PM CST

SHE:002198 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	350.56	383.75	376.17	533.23	659.2	574.71
Revenue Growth	-11.23%	2.02%	-29.45%	-19.11%	14.70%	5.50%
Gross Profit	189.89	226.12	224.04	346.9	429.98	431.45
Operating Income	13.41	40.5	20.75	35.56	50.22	29.29
Net Income	-2.58	30.48	20.61	34.32	43.93	1.48
Earnings Per Share	-0.01	0.06	0.04	0.07	0.09	0.00
EPS Growth	-	48.03%	-39.94%	-21.94%	2886.21%	-92.58%

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Pharmaceutical Industry	382.92	375.41	533.23	659.03	574.6
Unallocated Other	0.84	0.76	-	0.17	0.11
Total	383.75	376.17	533.23	659.2	574.71

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	128.45	177.11	336.14	335.74	236	242.89
Total Debt	20	-	-	-	-	31.11
Net Cash (Debt)	108.45	177.11	336.14	335.74	236	211.78
Net Cash Growth	-47.37%	-47.31%	0.12%	42.26%	11.44%	70.91%
Net Cash Per Share	0.21	0.35	0.66	0.66	0.47	0.42

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	-20.41	9	60.85	98.45	27.15	51.8
Capital Expenditures	-103.11	-109.92	-38.7	-5.06	-2.74	-2.34
Free Cash Flow	-123.52	-100.92	22.14	93.39	24.41	49.46
Free Cash Flow Growth	-	-	-76.29%	282.53%	-50.63%	-41.95%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	54.17%	58.92%	59.56%	65.05%	65.23%	75.07%
Operating Margin	3.82%	10.55%	5.51%	6.67%	7.62%	5.10%
Pretax Margin	0.67%	9.89%	6.67%	7.38%	7.75%	1.01%
Profit Margin	-0.74%	7.94%	5.48%	6.44%	6.67%	0.26%
FCF Margin	-35.23%	-26.30%	5.89%	17.51%	3.70%	8.61%

Dividends

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dividend Per Share	0.050
Dividend Per Share Growth	-
Dividend Yield	0.69%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	117.06	180.24	107.65	75.32	2707.14
Forward PE	-	21.70	21.70	21.70	21.70	21.70
P/FCF Ratio	-	-	167.76	39.56	135.53	80.86
PS Ratio	5.50	9.30	9.88	6.93	5.02	6.96